ABSTRACT
En las campañas de vacunación, como en la actual situación de COVID-19, es habitual que los países señalen posibles efectos adversos después de la vacunación. Esto no significa necesariamente que los eventos estén relacionados con la vacunación en sí, pero es necesario investigarlos. También muestra que el sistema de vigilancia funciona y que existen controles efectivos. La Organización Mundial de la Salud (OMS) está en contacto regular con la Agencia Europea de Medicamentos (EMA) y otras autoridades reguladoras del mundo para obtener la información más reciente sobre la seguridad de todas las vacunas para COVID-19.
Subject(s)
Humans , Pneumonia, Viral/immunology , Viral Vaccines/adverse effects , Coronavirus Infections/immunology , Upper Extremity Deep Vein Thrombosis/chemically induced , Pandemics/prevention & control , Betacoronavirus/immunology , Drug Monitoring/adverse effects , Immunization Programs/organization & administration , EuropeSubject(s)
Dantrolene/adverse effects , Malignant Hyperthermia/drug therapy , Upper Extremity Deep Vein Thrombosis/chemically induced , Adult , Dantrolene/administration & dosage , Dantrolene/therapeutic use , Humans , Male , Muscle Relaxants, Central/administration & dosage , Muscle Relaxants, Central/adverse effects , Muscle Relaxants, Central/therapeutic use , Upper Extremity Deep Vein Thrombosis/pathologyABSTRACT
The case is presented of a 41 year-old women with a personal history of smoking and treated with oral contraceptives, who began taking analgesics and muscle relaxants due to a right cervical pain. As her clinical condition did not improve she was seen again. During the physical examination an increase of soft tissue in the right supraclavicular area was observed. The ultrasound revealed thrombosis of the internal jugular, subclavian, brachycephalic, axillar and humeral veins. We believe that upper-extremity deep venous thrombosis is a rare condition that must be considered in patients with oedema of the upper limbs. The key to a prompt diagnosis is to know the risk factors. Ultrasound is the standard approach.
